U.S. Medical Equipment Stock News

NasdaqGS:TXN
NasdaqGS:TXNSemiconductor

Texas Instruments (TXN) Plans Dividend Hike, Is The Stock 41% Undervalued?

Texas Instruments (TXN) just put its dividend policy back in the spotlight with a planned 7% hike in the quarterly payout to $1.52 per share, subject to board approval. Texas Instruments shares have eased off their recent highs, with the 30-day share price return down 5.18% and the 90-day move down 20.05%. The stock still carries longer-term momentum, with a 45.81% 1-year total shareholder return and 75.36% over three years, as investors weigh the dividend increase, capacity buildout and data...
NYSE:LYV
NYSE:LYVEntertainment

Why Live Nation Entertainment (LYV) Is Getting Attention Now

Live Nation Entertainment (LYV) just posted Q2 2026 results that topped analyst expectations, with management lifting its outlook for revenue, adjusted operating income, fan growth, and margin expansion, putting the concert powerhouse back in the spotlight. Live Nation Entertainment's share price has eased in the short term, with a 1-month share price return down 6.39% and a 7-day share price return down 1.02%. At the same time, the year-to-date share price return sits at 15.85% and the...
NYSE:OKE
NYSE:OKEOil and Gas

Will $2 Billion Debt Tender Change ONEOK's (OKE) Narrative

ONEOK completed a corporate reorganization on September 10, 2026 and launched cash tender offers of up to US$2 billion for a range of senior notes, with early tenders already equaling the maximum aggregate amount. The combination of revised Oklahoma governance documents and a large debt repurchase program signals a focus on tighter control over key decisions and potential balance sheet repositioning that could influence long term financing costs. This article examines how ONEOK's investment...
NasdaqGS:AMBA
NasdaqGS:AMBASemiconductor

Learn Why The Bull Case For Ambarella (AMBA) Could Change Following Developer Zone Expansion

Ambarella expanded its Developer Zone, adding a Google Cloud hosted IDE, Gemini Enterprise powered agentic AI tools, and deeper ties with ZEDEDA and Ultralytics to support cloud connected fleets of CVflow based edge devices. The build once, deploy across 12 AI SoC families approach, spanning more than 200 supported model architectures and 50 million units in the field, points to a software style scale story layered on top of Ambarella’s chip base. The next area of focus is how Ambarella’s...
NYSE:CL
NYSE:CLHousehold Products

Will Premium Toothpaste Push Change Colgate's (CL) Narrative

Colgate-Palmolive's board declared a quarterly cash dividend of $0.53 per share, paid in November 2026, extending an uninterrupted payment record on its common stock that began in 1895. Management is pairing this long-running dividend commitment with increased support for premium toothpaste and higher advertising in North America as it works through recent category softness and tougher competition. We will now assess how Colgate-Palmolive's investment narrative could be influenced by this...
NYSE:BHE
NYSE:BHEElectronic

Benchmark Electronics (BHE) Could Be 13% Undervalued On Strong Q2 And Upbeat Guidance

Benchmark Electronics (BHE) has reaffirmed its quarterly dividend at $0.17 per share, following Q2 results that topped analyst expectations on both revenue and earnings and guidance that ran ahead of forecasts. At a share price of $74.55, Benchmark Electronics has seen strong momentum this year, with a year to date share price return of 69.82% and a 1 year total shareholder return of 85.22%. However, the 90 day share price return has declined 19.12% as expectations reset around the recent run...
NasdaqGS:GO
NasdaqGS:GOConsumer Retailing

Grocery Outlet Holding (GO) Lifted Full Year Guidance, Is The Rebound Already Priced In?

Grocery Outlet Holding (GO) just posted second quarter 2026 results, with net sales up 1.1%, comparable-store sales slipping 0.3%, higher full year guidance, and a net loss driven by a large non cash goodwill impairment. Grocery Outlet Holding’s share price has been rebuilding some short term momentum, with a 1-day share price return of 1.4%, a 7-day gain of 4.9%, and a 90-day move of 25.5% to US$11.62. However, the 1-year total shareholder return is still down 31.5%, pointing to a business...
NYSE:BF.B
NYSE:BF.BBeverage

3 US Dividend Stocks Built For Higher Rates

Fed rate hikes, sticky 3.5–4% inflation and higher borrowing costs are reshaping where reliable income might come from, especially as growth stocks feel the heat from higher-for-longer policy into 2027. That mix creates a window for dividend investors who want cash returns without leaning on guesswork about fast expansion stories. This article walks through three high-quality dividend stocks exposed to these macro shifts and what that could mean for your portfolio. The three stocks covered...
NYSE:DPC
NYSE:DPCElectrical

Is DPC Holdings (DPC) Undervalued After Refinancing Its Debt?

DPC Holdings (NYSE:DPC) has just overhauled its borrowing structure, securing a new US$325 million unsecured revolving credit facility and refinancing pre IPO debt. This move reshapes its liquidity profile. Investors have reacted cautiously to these financing moves, with DPC Holdings’ 1 month share price return down 18.52% and the year to date share price return down 13.82%. This is despite a 2.23% gain over the last trading day, which hints at stabilising momentum. Scan how lenders react to...
NasdaqGS:OSIS
NasdaqGS:OSISElectronic

Does Government Radio Orders Change The Bull Case For OSI Systems Stock (OSIS)?

OSI Systems reported that, earlier this week, its Security division received about US$90 million in U.S. Government orders for RF communication products and its Optoelectronics and Manufacturing unit secured roughly US$8 million of electronic assembly work from a global industrial technology client. The twin order wins highlight OSI Systems' exposure to government infrastructure programs and its ability to supply complex assemblies across multiple industrial product lines and...
NYSE:TRNO
NYSE:TRNOIndustrial REITs

Did Lease Renewals Just Shift Terreno Realty Stock Investment Narrative?

Terreno Realty Corporation has executed early renewals on leases for three Sunnyvale industrial buildings totaling 172,000 square feet with a leading molecular diagnostic testing provider, extending the lease expiries from March 2030 to March 2035. The five year extension with a single specialized tenant highlights Terreno Realty's ability to keep mission critical space occupied, which can support more predictable rental income from its Sunnyvale cluster. We will now examine how Terreno...
NYSE:BOW
NYSE:BOWInsurance

3 Insurance Stocks Tied To Energy And Shipping Risks Retail Investors Are Tracking

Energy supply routes are under strain, inflation has central banks on edge, and global trade patterns are being redrawn in real time. That mix is pushing risks tied to tankers, offshore platforms, and cargo into sharper focus, and insurance stocks linked to those flows are suddenly on many watchlists. This article walks through three stocks from our Global Energy Infrastructure and Shipping Insurance screener that appear positively exposed to these shocks and explains what could be driving...
NYSE:TSM
NYSE:TSMSemiconductor

Taiwan Semiconductor Manufacturing (TSM) Starts Commercial 2 Nm Production

Taiwan Semiconductor Manufacturing (NYSE:TSM) reports record revenue alongside higher capital spending as it advances leading edge chipmaking. The foundry begins commercial 2nm production while relying on ASML equipment that remains without a direct competing supplier. Management outlines a larger budget for advanced manufacturing capacity that targets future high performance computing and AI workloads. TSMC's record top line and 2nm ramp tell only part of how its plans intersect with ASML's...
NYSE:WLK
NYSE:WLKChemicals

Does Earnings Turnaround Change The Bull Case For Westlake (WLK)?

Westlake Corporation reported a second quarter turnaround, generating net income of US$260 million and shifting its Performance and Essential Materials segment from a US$318 million operating loss to US$185 million in operating income, supported by a 14% year over year rise in average sales prices. The group also reduced debt by US$500 million and returned US$99 million through dividends and buybacks, which highlights how Westlake is using the earnings recovery to clean up its balance sheet...
NasdaqGM:GPCR
NasdaqGM:GPCRPharmaceuticals

Structure Therapeutics (GPCR) As Fresh Obesity Data Tests Its 1.8x P B Valuation

Structure Therapeutics (GPCR) has put fresh clinical data at the center of its story, with new results from ACCG-2671 and aleniglipron in chronic weight management drawing investor attention this month. The fresh trial readouts arrive after a sharp pullback in Structure Therapeutics’ 1 month share price return, which fell 34.43%. This contributed to a 48.47% share price decline year to date, even as the 1 year total shareholder return is 51.10%, a mix that suggests recent enthusiasm has...
NYSE:GOLF
NYSE:GOLFLeisure

Acushnet Holdings (GOLF) Slides As Undervalued Calls Persist, Is The Premium Still Justified?

Acushnet Holdings (GOLF) is under renewed scrutiny after a recent pullback, with the share price down about 9% over the past month and roughly 24% over the past 3 months. The recent slide in Acushnet Holdings’ share price has softened short term momentum, yet the latest close at US$81.55 still sits against a backdrop of positive total shareholder return of 9.11% over one year and 72.58% over five years. This suggests that recent weakness reflects shifting sentiment on near term risks rather...
NYSE:PFE
NYSE:PFEPharmaceuticals

Pfizer (PFE), Why Is The Market Watching So Closely?

Pfizer (PFE) heads into the Morgan Stanley Global Healthcare Conference on 14 September with investors watching for fresh commentary from CEO Albert Bourla as the stock trades near US$27.64. Pfizer’s recent 90 day share price return of 9.64% and year to date share price return of 9.77% suggest improving momentum. The 1 year total shareholder return of 22.48% contrasts with a weaker 5 year total shareholder return, indicating a recovery story that investors are reassessing as new products,...
NasdaqGS:UPWK
NasdaqGS:UPWKProfessional Services

Upwork (UPWK), Why Is The Freelance Platform Drawing Fresh Attention?

Upwork (UPWK) has drawn fresh attention after recent trading left the stock around $8.52, with returns mixed across different time frames. Investors are weighing this move in light of the platform's role in global freelance and remote work demand. Recent trading paints a split picture for Upwork. The 90 day share price return is up 5.78%, yet the year to date share price move is down 57.08%, and the 1 year total shareholder return has declined 56.56%. This signals fading longer term momentum...
NasdaqGS:ISRG
NasdaqGS:ISRGMedical Equipment

Intuitive Surgical (ISRG) Wins EU Approval As Its Undervalued Narrative Faces A Fresh Test

Intuitive Surgical (ISRG) just secured CE mark approval for transvaginal gynecologic procedures on its da Vinci SP system in Europe, a world first that broadens the platform’s minimally invasive surgery footprint. That regulatory win lands at an interesting moment for Intuitive Surgical, with the stock at US$383.54 after a 6.4% 7-day share price return but a year-to-date share price decline of 31.75%, while the 3-year total shareholder return of 34.88% points to much stronger longer run...
NYSE:BDX
NYSE:BDXMedical Equipment

Becton Dickinson (BDX), Why Is Fresh Attention Building Around It?

Becton Dickinson (BDX) is back under the regulatory spotlight after a December 2024 SEC order found repeated misstatements around risks tied to its Alaris infusion pump, resulting in a US$175m civil penalty. The recent SEC order lands at a time when Becton Dickinson’s share price has already been through a sharp swing, with a 90 day share price return of 25.98%, a year to date share price decline of 6.96%, and a relatively modest 5 year total shareholder return of 2.03% that contrasts with a...
NasdaqGS:AVO
NasdaqGS:AVOFood

Can Mission Produce (AVO) Justify Its Valuation On Higher Avocado Volumes And Synergies?

Mission Produce (AVO) just paired a sharp jump in third quarter revenue with new avocado production guidance and an updated synergy target from its Calavo deal, giving investors fresh numbers to reassess the stock. The fresh production guidance and synergy update land after a choppy stretch for Mission Produce’s stock, with the share price down 5.9% over the past week and 4.7% over the past month. The stock still shows a 90-day share price return of 8.4% and a 3-year total shareholder return...
NYSE:CON
NYSE:CONHealthcare

Concentra Group Holdings Parent (CON) Could Be 11% Undervalued After Earnings Beat And Florida Expansion

Concentra Group Holdings Parent (CON) is back in focus after another earnings beat and the launch of a new occupational health center in Daytona Beach, Florida, a move tied directly to Florida network expansion. The latest Daytona expansion and leadership succession news arrive as Concentra Group Holdings Parent trades at US$35.53, with the share price return up 24.4% over 90 days and 83.1% year to date. The 1-year total shareholder return is 70.7%, suggesting momentum has been building...
NYSE:FMC
NYSE:FMCChemicals

FMC (FMC) Advances RNA Bioinsecticides, Is The Stock 25% Undervalued?

FMC Corporation (FMC) moved into the spotlight after announcing that two RNA-based bioinsecticide candidates with AgroSpheres are progressing into global field trials across the United States, Brazil and Asia. For FMC, the RNA bioinsecticide milestone is landing against a weak price backdrop, with the share price down 28.87% year to date and posting a 1-year total shareholder return decline of 71.61% as dividend cuts and past setbacks continue to weigh on sentiment. Over three and five years,...
NasdaqGM:DAVE
NasdaqGM:DAVEConsumer Finance

Dave (DAVE) Shares Moved, So What Is Driving Attention Now?

Attention on Dave (DAVE) has picked up as investors focus on the upcoming CashAI v5.5 rollout, which is expected to influence credit performance, advance sizes, loss rates, and overall profitability for the platform. Recent trading reflects that optimism. Dave’s 1 month share price return of 7.01% and 90 day share price return of 13.37% sit alongside a 62.42% year to date share price gain, while the 3 year total shareholder return is very large, which points to strong momentum built over...